Skip to main content
Top
Published in: Critical Care 3/2005

Open Access 01-06-2005 | Research

Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case–control study

Authors: Saad Nseir, Christophe Di Pompeo, Stéphane Soubrier, Hélène Lenci, Pierre Delour, Thierry Onimus, Fabienne Saulnier, Daniel Mathieu, Alain Durocher

Published in: Critical Care | Issue 3/2005

Login to get access

Abstract

Introduction

Our objective was to determine the effect of ventilator-associated tracheobronchitis (VAT) on outcome in patients without chronic respiratory failure.

Methods

This was a retrospective observational matched study, conducted in a 30-bed intensive care unit (ICU). All immunocompetent, nontrauma, ventilated patients without chronic respiratory failure admitted over a 6.5-year period were included. Data were collected prospectively. Patients with nosocomial pneumonia, either before or after VAT, were excluded. Only first episodes of VAT occurring more than 48 hours after initiation of mechanical ventilation were studied. Six criteria were used to match cases with controls, including duration of mechanical ventilation before VAT. Cases were compared with controls using McNemar's test and Wilcoxon signed-rank test for qualitative and quantitative variables, respectively. Variables associated with a duration of mechanical ventilation longer than median were identified using univariate and multivariate analyses.

Results

Using the six criteria, it was possible to match 55 (87%) of the VAT patients (cases) with non-VAT patients (controls). Pseudomonas aeruginosa was the most frequently isolated bacteria (34%). Although mortality rates were similar between cases and controls (29% versus 36%; P = 0.29), the median duration of mechanical ventilation (17 days [range 3–95 days] versus 8 [3–61 days]; P < 0.001) and ICU stay (24 days [range 5–95 days] versus 12 [4–74] days; P < 0.001) were longer in cases than in controls. Renal failure (odds ratio [OR] = 4.9, 95% confidence interval [CI] = 1.6–14.6; P = 0.004), tracheostomy (OR = 4, 95% CI = 1.1–14.5; P = 0.032), and VAT (OR = 3.5, 95% CI = 1.5–8.3; P = 0.004) were independently associated with duration of mechanical ventilation longer than median.

Conclusion

VAT is associated with longer durations of mechanical ventilation and ICU stay in patients not suffering from chronic respiratory failure.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995, 274: 639-644. 10.1001/jama.274.8.639CrossRefPubMed Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995, 274: 639-644. 10.1001/jama.274.8.639CrossRefPubMed
2.
go back to reference Rello J, Ausina V, Castella J, Net A, Prats G: Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992, 102: 525-529.CrossRefPubMed Rello J, Ausina V, Castella J, Net A, Prats G: Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992, 102: 525-529.CrossRefPubMed
3.
go back to reference Bouza E, Perez A, Munoz P, Jesus Perez M, Rincon C, Sanchez C, Martin-Rabadan P, Riesgo M: Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003, 31: 1964-1970. 10.1097/01.ccm.0000084807.15352.93CrossRefPubMed Bouza E, Perez A, Munoz P, Jesus Perez M, Rincon C, Sanchez C, Martin-Rabadan P, Riesgo M: Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003, 31: 1964-1970. 10.1097/01.ccm.0000084807.15352.93CrossRefPubMed
4.
go back to reference Nseir S, Di Pompeo C, Pronnier P, Beague S, Onimus T, Saulnier F, Grandbastien B, Mathieu D, Delvallez-Roussel M, Durocher A: Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002, 20: 1483-1489. 10.1183/09031936.02.00012902CrossRefPubMed Nseir S, Di Pompeo C, Pronnier P, Beague S, Onimus T, Saulnier F, Grandbastien B, Mathieu D, Delvallez-Roussel M, Durocher A: Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002, 20: 1483-1489. 10.1183/09031936.02.00012902CrossRefPubMed
5.
go back to reference Marquette CH, Georges H, Wallet F, Ramon P, Saulnier F, Neviere R, Mathieu D, Rime A, Tonnel AB: Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 1993, 148: 138-144.CrossRefPubMed Marquette CH, Georges H, Wallet F, Ramon P, Saulnier F, Neviere R, Mathieu D, Rime A, Tonnel AB: Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 1993, 148: 138-144.CrossRefPubMed
6.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16: 128-140.CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16: 128-140.CrossRefPubMed
7.
go back to reference Anonymous: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987, 136: 225-244.CrossRef Anonymous: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987, 136: 225-244.CrossRef
8.
go back to reference Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRefPubMed
10.
11.
go back to reference Palmer LB, Smaldone GC, Simon S, O'Riordan T, Morra L: Tracheal aspirates in long-term mechanically ventilated patients. A human model of gram-negative infection and airway inflammation. Chest 1995, 108: 1326-1332.CrossRefPubMed Palmer LB, Smaldone GC, Simon S, O'Riordan T, Morra L: Tracheal aspirates in long-term mechanically ventilated patients. A human model of gram-negative infection and airway inflammation. Chest 1995, 108: 1326-1332.CrossRefPubMed
12.
go back to reference Cohen J, Brun-Buisson C, Torres A, Jorgensen J: Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 2004, 32: S466-S494. 10.1097/01.CCM.0000145917.89975.F5CrossRefPubMed Cohen J, Brun-Buisson C, Torres A, Jorgensen J: Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 2004, 32: S466-S494. 10.1097/01.CCM.0000145917.89975.F5CrossRefPubMed
13.
go back to reference Safdar N, Maki DG: The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus , enterococcus, gram-negative bacilli, Clostridium difficile , and Candida . Ann Intern Med 2002, 136: 834-844.CrossRefPubMed Safdar N, Maki DG: The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus , enterococcus, gram-negative bacilli, Clostridium difficile , and Candida . Ann Intern Med 2002, 136: 834-844.CrossRefPubMed
14.
go back to reference Ahmed QA, Niederman MS: Respiratory infection in the chronically critically ill patient. Ventilator-associated pneumonia and tracheobronchitis. Clin Chest Med 2001, 22: 71-85.CrossRefPubMed Ahmed QA, Niederman MS: Respiratory infection in the chronically critically ill patient. Ventilator-associated pneumonia and tracheobronchitis. Clin Chest Med 2001, 22: 71-85.CrossRefPubMed
15.
go back to reference Hamer DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000, 162: 328-330.CrossRefPubMed Hamer DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000, 162: 328-330.CrossRefPubMed
16.
go back to reference Kollef MH, Fraser VJ: Antibiotic resistance in the intensive care unit. Ann Intern Med 2001, 134: 298-314.CrossRefPubMed Kollef MH, Fraser VJ: Antibiotic resistance in the intensive care unit. Ann Intern Med 2001, 134: 298-314.CrossRefPubMed
17.
go back to reference Nseir S, Di Pompeo C, Soubrier S, Delour P, Lenci H, Roussel-Delvallez M, Onimus T, Saulnier F, Mathieu D, Durocher A: First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 2005, 33: 283-289. 10.1097/01.CCM.0000152230.53473.A1CrossRefPubMed Nseir S, Di Pompeo C, Soubrier S, Delour P, Lenci H, Roussel-Delvallez M, Onimus T, Saulnier F, Mathieu D, Durocher A: First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 2005, 33: 283-289. 10.1097/01.CCM.0000152230.53473.A1CrossRefPubMed
18.
go back to reference Anonymous: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171: 388-416. 10.1164/rccm.200405-644STCrossRef Anonymous: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171: 388-416. 10.1164/rccm.200405-644STCrossRef
19.
go back to reference Snow V, Mottur-Pilson C, Gonzales R: Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001, 134: 518-520.CrossRefPubMed Snow V, Mottur-Pilson C, Gonzales R: Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001, 134: 518-520.CrossRefPubMed
20.
go back to reference King DE, Williams WC, Bishop L, Shechter A: Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 1996, 42: 601-605.PubMed King DE, Williams WC, Bishop L, Shechter A: Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 1996, 42: 601-605.PubMed
21.
go back to reference Verheij TJ, Hermans J, Mulder JD: Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract 1994, 44: 400-404.PubMedCentralPubMed Verheij TJ, Hermans J, Mulder JD: Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract 1994, 44: 400-404.PubMedCentralPubMed
22.
go back to reference Williamson HA Jr: A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 1984, 19: 481-486.PubMed Williamson HA Jr: A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 1984, 19: 481-486.PubMed
23.
go back to reference Brickfield FX, Carter WH, Johnson RE: Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract 1986, 23: 119-122.PubMed Brickfield FX, Carter WH, Johnson RE: Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract 1986, 23: 119-122.PubMed
24.
go back to reference Franks P, Gleiner JA: The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract 1984, 19: 185-190.PubMed Franks P, Gleiner JA: The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract 1984, 19: 185-190.PubMed
25.
go back to reference Dunlay J, Reinhardt R, Roi LD: A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 1987, 25: 137-141.PubMed Dunlay J, Reinhardt R, Roi LD: A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 1987, 25: 137-141.PubMed
26.
go back to reference Orr PH, Scherer K, Macdonald A, Moffatt ME: Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 1993, 36: 507-512.PubMed Orr PH, Scherer K, Macdonald A, Moffatt ME: Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 1993, 36: 507-512.PubMed
27.
go back to reference MacKay DN: Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996, 11: 557-562.CrossRefPubMed MacKay DN: Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996, 11: 557-562.CrossRefPubMed
28.
go back to reference Fahey T, Stocks N, Thomas T: Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 1998, 316: 906-910.PubMedCentralCrossRefPubMed Fahey T, Stocks N, Thomas T: Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 1998, 316: 906-910.PubMedCentralCrossRefPubMed
29.
go back to reference Smucny JJ, Becker LA, Glazier RH, McIsaac W: Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998, 47: 453-460.PubMed Smucny JJ, Becker LA, Glazier RH, McIsaac W: Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998, 47: 453-460.PubMed
30.
go back to reference Bent S, Saint S, Vittinghoff E, Grady D: Antibiotics in acute bronchitis: a meta-analysis. Am J Med 1999, 107: 62-67. 10.1016/S0002-9343(99)00167-9CrossRefPubMed Bent S, Saint S, Vittinghoff E, Grady D: Antibiotics in acute bronchitis: a meta-analysis. Am J Med 1999, 107: 62-67. 10.1016/S0002-9343(99)00167-9CrossRefPubMed
31.
go back to reference Ioanas M, Ewig S, Torres A.: Treatment failures in patients with ventilator-associated pneumonia. Infect Dis Clin North Am 2003, 17: 753-771. 10.1016/S0891-5520(03)00070-9CrossRefPubMed Ioanas M, Ewig S, Torres A.: Treatment failures in patients with ventilator-associated pneumonia. Infect Dis Clin North Am 2003, 17: 753-771. 10.1016/S0891-5520(03)00070-9CrossRefPubMed
Metadata
Title
Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case–control study
Authors
Saad Nseir
Christophe Di Pompeo
Stéphane Soubrier
Hélène Lenci
Pierre Delour
Thierry Onimus
Fabienne Saulnier
Daniel Mathieu
Alain Durocher
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2005
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3508

Other articles of this Issue 3/2005

Critical Care 3/2005 Go to the issue